What is the competitive landscape for JANSSEN BIOTECH, and when can generic versions of JANSSEN BIOTECH drugs launch?
has one approved drug.
There are two US patents protecting JANSSEN BIOTECH drugs and there have been two Paragraph IV challenges on JANSSEN BIOTECH drugs in the past three years.
There are sixty-five patent family members
on JANSSEN BIOTECH drugs in twenty-six countries and eight supplementary protection certificates
in eight countries.